Candriam Equities L Biotech.C EUR/ LU1120766388 /
| NAV6/13/2024 | Chg.+1.7900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 226.9600EUR | +0.80% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 6/16/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 6/3/2024 | Prospectus | 2024 | English | 3,663.84 KB |
| 6/3/2024 | Prospectus | 2024 | German | 5,520.88 KB |
| 3/1/2024 | PRIIP Key Information Document | 2024 | German | 268.47 KB |
| 12/31/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 12/31/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 12/1/2022 | Key Investor Information | 2022 | German | 363.93 KB |
